IL17A and prostate cancer: It has also been found that IL-17 increases the expression of VCAM-1 in vascular endothelial cells through CD44-VCAM-1 interaction, thereby enhancing the adhesion of PCa cells to vascular endothelial cells to promote prostate cancer metastasis (143).